FDA Approved: ALOPRIM — Supplemental Application (Mylan Institutional LLC)

View source ↗

Summary

The FDA approved a supplemental application for ALOPRIM (allopurinol) submitted by Mylan Institutional LLC, resulting in updated labeling.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Gout
• Hyperuricemia
• Tumor Lysis Syndrome
• Uric Acid Nephrolithiasis

Drugs mentioned

• ALOPRIM (allopurinol)

Snippet

SUPPL AP for ALOPRIM (ALLOPURINOL)